304 related articles for article (PubMed ID: 23845443)
1. Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome.
Rhyasen GW; Bolanos L; Fang J; Jerez A; Wunderlich M; Rigolino C; Mathews L; Ferrer M; Southall N; Guha R; Keller J; Thomas C; Beverly LJ; Cortelezzi A; Oliva EN; Cuzzola M; Maciejewski JP; Mulloy JC; Starczynowski DT
Cancer Cell; 2013 Jul; 24(1):90-104. PubMed ID: 23845443
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
3. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-κB signaling pathway.
Zhang X; Guo Y; Xu X; Tang T; Sun L; Wang H; Zhou W; Fang L; Li Q; Xie P
Virus Res; 2019 Oct; 271():197671. PubMed ID: 31330207
[TBL] [Abstract][Full Text] [Related]
4. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
[TBL] [Abstract][Full Text] [Related]
5. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
[TBL] [Abstract][Full Text] [Related]
6. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.
Bennett J; Ishikawa C; Agarwal P; Yeung J; Sampson A; Uible E; Vick E; Bolanos LC; Hueneman K; Wunderlich M; Kolt A; Choi K; Volk A; Greis KD; Rosenbaum J; Hoyt SB; Thomas CJ; Starczynowski DT
Blood; 2023 Sep; 142(11):989-1007. PubMed ID: 37172199
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-146b-5p Ameliorates Neonatal Hypoxic Ischemic Encephalopathy by Inhibiting IRAK1/TRAF6/TAK1/NF-αB Signaling.
Yang G; Zhao Y
Yonsei Med J; 2020 Aug; 61(8):660-669. PubMed ID: 32734729
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.
Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE
J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.
Ji L; Hou X; Liu W; Deng X; Jiang Z; Huang K; Li R
Microb Pathog; 2018 Nov; 124():223-229. PubMed ID: 30149133
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
Kerbauy DM; Lesnikov V; Abbasi N; Seal S; Scott B; Deeg HJ
Blood; 2005 Dec; 106(12):3917-25. PubMed ID: 16105982
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins.
Park H; Huang X; Lu C; Cairo MS; Zhou X
J Biol Chem; 2015 Jan; 290(5):2831-41. PubMed ID: 25505246
[TBL] [Abstract][Full Text] [Related]
12. Role of IRAK1 on TNF-induced proliferation and NF-ĸB activation in human bone marrow mesenchymal stem cells.
Kim JM; Cho HH; Lee SY; Hong CP; Yang Jw; Kim YS; Suh KT; Jung JS
Cell Physiol Biochem; 2012; 30(1):49-60. PubMed ID: 22759955
[TBL] [Abstract][Full Text] [Related]
13. IRAK1: oncotarget in MDS and AML.
Beverly LJ; Starczynowski DT
Oncotarget; 2014 Apr; 5(7):1699-700. PubMed ID: 24880611
[No Abstract] [Full Text] [Related]
14. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
15. β-TrCP-mediated IRAK1 degradation releases TAK1-TRAF6 from the membrane to the cytosol for TAK1-dependent NF-κB activation.
Cui W; Xiao N; Xiao H; Zhou H; Yu M; Gu J; Li X
Mol Cell Biol; 2012 Oct; 32(19):3990-4000. PubMed ID: 22851693
[TBL] [Abstract][Full Text] [Related]
16. The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.
Zhou L; Chen S; Zhang Y; Kmieciak M; Leng Y; Li L; Lin H; Rizzo KA; Dumur CI; Ferreira-Gonzalez A; Rahmani M; Povirk L; Chalasani S; Berger AJ; Dai Y; Grant S
Blood; 2016 May; 127(18):2219-30. PubMed ID: 26851293
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a and its adapter proteins are affected by diabetes in rat's heart.
Eftekhar E; Doustaki Zaboli M; Katebi M; Soufi FG
Bratisl Lek Listy; 2016; 117(3):166-70. PubMed ID: 26925748
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.
Li Z; Younger K; Gartenhaus R; Joseph AM; Hu F; Baer MR; Brown P; Davila E
J Clin Invest; 2015 Mar; 125(3):1081-97. PubMed ID: 25642772
[TBL] [Abstract][Full Text] [Related]
19. The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition.
Kamali K; Korjan ES; Eftekhar E; Malekzadeh K; Soufi FG
Bratisl Lek Listy; 2016; 117(7):376-80. PubMed ID: 27546538
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88.
Chen BC; Wu WT; Ho FM; Lin WW
J Biol Chem; 2002 Jul; 277(27):24169-79. PubMed ID: 11976320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
